Document Detail

Metal oxyanion stabilization of the rat glucocorticoid receptor is independent of thiols.
MedLine Citation:
PMID:  7929266     Owner:  NLM     Status:  MEDLINE    
The ability of sodium molybdate, both to stabilize the steroid binding activity of glucocorticoid receptors and to prevent the activation of receptor-steroid complexes to a DNA binding species, has long been thought to involve thiols. Two receptor thiols in particular, Cys-656 and Cys-661 of rat receptors, have been suspected. The requirements for the action of molybdate, as well as two other metal oxyanions (tungstate and vanadate) known to exert the same effects as molybdate, have now been examined with receptors in which these thiols, or a third cysteine in the steroid binding cavity (Cys-640), have been mutated to serine. No mutation prevented any metal oxyanion from either stabilizing steroid-free receptors or blocking the activation of complexes for binding to nonspecific or specific DNA sequences. Thus, Cys-640, Cys-656, and Cys-661 are not required for any of the effects of molybdate, tungstate, or vanadate with rat glucocorticoid receptors. Studies with hybrid receptors, and with a 16-kDa steroid binding core fragment containing only 3 cysteines at positions 640, 656, and 661, indicated that no cysteine of the rat receptor was needed to maintain responsiveness to molybdate. Even when all of the thiol groups in crude cytosol were blocked by reaction with excess methyl methanethiol-sulfonate, each metal oxyanion was still able to stabilize the steroid binding of receptors. These results argue that molybdate, tungstate, and vanadate each interact with the receptor or an associated nonreceptor protein(s) in a manner that does not require thiols. An indirect mechanism of molybdate action was evaluated in light of the recent report that the whole cell actions are mediated by increased levels of intracellular cGMP. Under cell-free conditions, however, the effects of molybdate could not be reproduced by cGMP derivatives. Evidence consistent with a direct effect was that molybdate, tungstate, or vanadate each modified the kinetics of proteolysis of wild type receptors at 0 degrees C by trypsin, presumably due to induced conformational changes of the receptor. This alteration of trypsin digestion constitutes yet another effect of metal oxyanions on the glucocorticoid receptor.
K J Modarress; A H Cavanaugh; P K Chakraborti; S S Simons
Related Documents :
16787166 - New insights into the molecular mechanisms of corticosteroids actions.
19595676 - Cellular mechanisms underlying affective resiliency: the role of glucocorticoid recepto...
9697656 - 11beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive...
8074206 - Type i (mineralocorticoid) receptors in the guinea pig.
18771256 - Flexible side chain models improve enrichment rates in in silico screening.
3304726 - Potential use of da1 and da2 receptor agonists in the treatment of hypertension.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  269     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  1994 Oct 
Date Detail:
Created Date:  1994-11-17     Completed Date:  1994-11-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  25621-8     Citation Subset:  IM    
Steroid Hormones Section, NIDDK/LMCB, National Institutes of Health, Bethesda, Maryland 20892.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Affinity Labels
Anions / pharmacology
Base Sequence
Cyclic GMP / analogs & derivatives
Cysteine / genetics,  metabolism
Dexamethasone / analogs & derivatives,  metabolism*
Methyl Methanesulfonate / analogs & derivatives,  pharmacology
Molecular Sequence Data
Molybdenum / pharmacology*
Peptide Fragments / metabolism
Receptors, Glucocorticoid / drug effects,  genetics,  metabolism*
Structure-Activity Relationship
Sulfhydryl Compounds / metabolism
Trypsin / metabolism
Tungsten Compounds / pharmacology*
Vanadates / pharmacology*
Reg. No./Substance:
0/Affinity Labels; 0/Anions; 0/Peptide Fragments; 0/Receptors, Glucocorticoid; 0/Sulfhydryl Compounds; 0/Tungsten Compounds; 0/Vanadates; 14259-85-9/molybdate; 2265-22-7/dexamethasone 21-methanesulfonate; 2949-92-0/methyl methanethiosulfonate; 50-02-2/Dexamethasone; 51682-10-1/tungstate; 52-90-4/Cysteine; 66-27-3/Methyl Methanesulfonate; 7439-98-7/Molybdenum; 7665-99-8/Cyclic GMP; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transacti...
Next Document:  The topology of the S protein in the yeast-derived hepatitis B surface antigen particles.